Market Movers (8-K)
NASDAQ
Exyn Technologies announces the immediate resignation of CEO Brandon Torres Declet following an internal investigation into personal expenses charged to the company, with Benjamin Williams appointed as interim CEO.
Worse than expected
NASDAQ
Exyn Technologies announced its second quarter 2026 financial results, reporting a revenue of $950 thousand, a decrease from the prior year, alongside strategic advancements in its defense sector and a leadership transition.
Worse than expected
Quarterly Earnings (10-Q)
NASDAQ
Exyn Technologies amends its Q2 2026 10-Q filing to correct disclosures regarding former CEO's departure and segment reporting, while highlighting ongoing operational losses and a going concern warning.
Worse than expected
Capital raise
NASDAQ
Exyn Technologies, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing a significant increase in operating losses, a going concern warning, and the termination of its former CEO.
Worse than expected
Capital raise
NASDAQ
Exyn Technologies reports a slight revenue decrease in Q1 2026, but improved gross profit, while operating expenses increased due to strategic investments.
Worse than expected
Capital raise
Insider Trading (Form 4)
NASDAQ
Gregory S. Mcneal, a Director of Exyn Technologies, Inc., received 23,200 shares of common stock on August 3, 2026.
NASDAQ
Declet Brandon Torres, Chief Executive Officer and a Director of Exyn Technologies, Inc., received 109,000 shares of common stock on August 3, 2026.
NASDAQ
Ted L Tewksbury Iii, a Director of Exyn Technologies, Inc., received 23,200 shares of common stock on August 3, 2026.
NASDAQ
Jonathan Carey Ollwerther, a Director of Exyn Technologies, Inc., received 23,200 shares of common stock on August 3, 2026.
NASDAQ
Michael Burychka, a Director of Exyn Technologies, Inc., received 23,200 shares of common stock on August 3, 2026.
New Public Companies (S-1)
NASDAQ
Exyn Technologies, Inc., a pioneer in autonomous robotics, has filed an S-1 registration statement with the SEC to allow for the resale of up to 3,658,564 shares of common stock and 189,753 warrants by selling stockholders.
Capital raise
Worse than expected